Interleukin‐7 (IL‐7), which is a common gamma‐chain cytokine that plays critical roles in maintaining lymphocyte homeostasis, has been suggested to reverse lymphopenia and improve clinical outcomes of cancer patients.12, 13. Here, IL7 is linked to lymphopenia.